CO-ADD is a not-for-profit global initiative led by IMB Cooper Research Group for academics. Our goal is to screen compounds from academic research groups from anywhere in the world for free. We aim to help researchers around the world to find new, diverse compounds to combat the superbug crisis, priming the antibiotic drug discovery pipeline.

Submit your compounds at www.co-add.org

Project members

Key contact

Dr Mark Blaskovich

Director, IMB Centre for Superbug Solutions
Principal Research Fellow - GL
Institute for Molecular Bioscience